Outcomes Of Salvage Haploidentical Transplant With Post-Transplant Cyclophosphamide For Rescuing Primary Graft Failure Patients : A Report By The Sfgm-Tc

Prognosis of graft failure patients is dismal, and another transplant is the sole option for long-term survival. Currently, there is no consensus concerning the best option for treating patients undergoing primary graft failure and finding a new donor within an acceptable delay is challenging. In the last years, haploidentical transplants with post-transplant cyclophosphamide (PT-Cy) have shown acceptable results in the treatment of many hematological diseases, including some cases of graft failure.